PL365101A1 - N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad - Google Patents

N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad

Info

Publication number: PL365101A1
Authority: PL; Poland
Prior art keywords: phenpropylcyclopentyl; fsad; nep inhibitors; substituted glutaramide; glutaramide derivatives
Prior art date: 2001-03-28

Application number

PL02365101A

Other languages

English (en)

Polish (pl)

Inventor

Stephen Challenger

Andrew Simon Cook

Adam Thomas Gillmore

Donald Stuard Middleton

David Cameron Pryde

Alan Stobie

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-28

Filing date

2002-03-18

Publication date

2004-12-27

2001-03-28 Priority claimed from GB0107750A external-priority patent/GB0107750D0/en

2001-05-30 Priority claimed from GB0113112A external-priority patent/GB0113112D0/en

2001-08-17 Priority claimed from GB0120152A external-priority patent/GB0120152D0/en

2002-03-18 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2004-12-27 Publication of PL365101A1 publication Critical patent/PL365101A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Dispersion Chemistry (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

PL02365101A 2001-03-28 2002-03-18 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad PL365101A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0107750A GB0107750D0 (en)	2001-03-28	2001-03-28	Novel pharmaceuticals
GB0113112A GB0113112D0 (en)	2001-05-30	2001-05-30	Novel pharmaceuticals
GB0120152A GB0120152D0 (en)	2001-08-17	2001-08-17	Novel pharmaceuticals
PCT/IB2002/000807 WO2002079143A1 (fr)	2001-03-28	2002-03-18	Derives de guataramide n-phenpropylcyclopentyl-substitues utilises comme inhibiteurs nep pour fsad

Publications (1)

Publication Number	Publication Date
PL365101A1 true PL365101A1 (en)	2004-12-27

Family

ID=27256128

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02365101A PL365101A1 (en)	2001-03-28	2002-03-18	N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad

Country Status (34)

Country	Link
EP (1)	EP1373192A1 (fr)
JP (1)	JP4018545B2 (fr)
KR (1)	KR100564466B1 (fr)
CN (1)	CN1243723C (fr)
AP (1)	AP1689A (fr)
AR (1)	AR035795A1 (fr)
BG (1)	BG108130A (fr)
BR (1)	BR0208455A (fr)
CA (1)	CA2437113A1 (fr)
CZ (1)	CZ20032534A3 (fr)
DO (1)	DOP2002000364A (fr)
EA (1)	EA006154B1 (fr)
EE (1)	EE200300469A (fr)
GE (1)	GEP20063783B (fr)
HK (1)	HK1060724A1 (fr)
HR (1)	HRP20030751A2 (fr)
HU (1)	HUP0303624A3 (fr)
IL (1)	IL157009A0 (fr)
IS (1)	IS6877A (fr)
MA (1)	MA26996A1 (fr)
MX (1)	MXPA03006597A (fr)
MY (1)	MY134081A (fr)
NO (1)	NO20034299L (fr)
NZ (1)	NZ527012A (fr)
OA (1)	OA12553A (fr)
PA (1)	PA8542401A1 (fr)
PE (1)	PE20021014A1 (fr)
PL (1)	PL365101A1 (fr)
RS (1)	RS75303A (fr)
SK (1)	SK11822003A3 (fr)
TN (1)	TNSN02032A1 (fr)
TW (1)	TWI254038B (fr)
UY (1)	UY27227A1 (fr)
WO (1)	WO2002079143A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040014761A1 (en) *	1997-10-28	2004-01-22	Place Virgil A.	Treatment of female sexual dysfunction with phosphodiesterase inhibitors
US7183410B2 (en)	2001-08-02	2007-02-27	Bidachem S.P.A.	Stable polymorph of flibanserin
US10675280B2 (en)	2001-10-20	2020-06-09	Sprout Pharmaceuticals, Inc.	Treating sexual desire disorders with flibanserin
UA78974C2 (en)	2001-10-20	2007-05-10	Boehringer Ingelheim Pharma	Use of flibanserin for treating disorders of sexual desire
WO2003039524A1 (fr) *	2001-11-09	2003-05-15	Pharmacia Ab	Agent anti-muscarinique et agoniste des oestrogenes pour traiter une vessie instable ou hyperactive
GB0130219D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Compounds for the treatment of sexual dysfunction
GB0230036D0 (en) *	2002-12-23	2003-01-29	Pfizer Ltd	Novel pharmaceuticals
GB0230025D0 (en) *	2002-12-23	2003-01-29	Pfizer Ltd	Novel pharmaceuticals
PA8597401A1 (es) *	2003-03-14	2005-05-24	Pfizer	Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US7262184B2 (en)	2003-09-26	2007-08-28	Solvay Pharmaceuticals Gmbh	Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en)	2003-09-26	2008-11-18	Solvay Pharmaceuticals Gmbh	Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en)	2003-09-26	2008-09-23	Solvay Pharmaceuticals Gmbh	Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
AU2005239962B2 (en)	2004-05-11	2011-07-07	Eb Ip Lybrido B.V.	Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
US20060025420A1 (en) *	2004-07-30	2006-02-02	Boehringer Ingelheimn International GmbH	Pharmaceutical compositions for the treatment of female sexual disorders
WO2006027680A1 (fr) *	2004-09-10	2006-03-16	Pfizer Limited	Derives d'acide 3-(1-carbamoylcyclohexyl)propionique comme inhibiteurs de l'enzyme endopeptidase neutre
EP1912650B8 (fr)	2005-08-03	2017-10-18	Sprout Pharmaceuticals, Inc.	Utilisation de la flibansérine dans le traitement de l'obésité
CA2626134C (fr)	2005-10-29	2013-12-24	Boehringer Ingelheim International Gmbh	Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme
EP1790343A1 (fr) *	2005-11-11	2007-05-30	Emotional Brain B.V.	Compositions pharmaceutiques et leur utilisation pour le traitement des dysfonctions sexuelles chez la femme
DE602007004615D1 (de)	2006-06-30	2010-03-18	Boehringer Ingelheim Pharma	Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EA200900264A1 (ru)	2006-08-14	2009-08-28	Бёрингер Ингельхайм Интернациональ Гмбх	Композиции флибансерина и способ их приготовления
CN101505736A (zh)	2006-08-25	2009-08-12	贝林格尔.英格海姆国际有限公司	控制释放系统及其制造方法
US8198311B2 (en) *	2006-11-01	2012-06-12	Bristol-Myers Squibb Company	Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP1925307A1 (fr)	2006-11-03	2008-05-28	Emotional Brain B.V.	Utilisation de 3-alpha-androstanediol pour le traitement des dysfonctions sexuelles
CL2008002693A1 (es)	2007-09-12	2009-10-16	Boehringer Ingelheim Int	Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
US8877815B2 (en)	2010-11-16	2014-11-04	Novartis Ag	Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8993631B2 (en)	2010-11-16	2015-03-31	Novartis Ag	Method of treating contrast-induced nephropathy
EP3082428A4 (fr)	2013-12-09	2017-08-02	Respira Therapeutics, Inc.	Formulations en poudre d'inhibiteur pde5 et procédés y associés
SI3303330T1 (sl)	2015-06-03	2019-08-30	Bristol-Myers Squibb Company	Agonisti 4-hidroksi-3-(heteroaril)piridin-2-on apj za uporabo pri zdravljenju kardiovaskularnih motenj
MX2019006938A (es)	2016-12-14	2019-09-06	Respira Therapeutics Inc	Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
CN107746400A (zh) *	2017-12-04	2018-03-02	武汉药明康德新药开发有限公司	苯并二氢吡喃‑6‑磺酰氯的制备方法
BR112020018094A2 (pt)	2018-03-08	2020-12-22	Incyte Corporation	Compostos de aminopirazina diol como inibidores de pi3k-¿
US11046658B2 (en)	2018-07-02	2021-06-29	Incyte Corporation	Aminopyrazine derivatives as PI3K-γ inhibitors
CN110483403A (zh) *	2019-09-02	2019-11-22	南通大学	一种5-溴-4-甲氧基-1h-吲唑的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH075530B2 (ja)	1989-11-21	1995-01-25	シェリング・コーポレーション	カルボキシアルキルカルボニルアミノ酸エンドペプチダーゼ阻害剤
GB9000725D0 (en)	1990-01-12	1990-03-14	Pfizer Ltd	Therapeutic agents
GB9004260D0 (en)	1990-02-26	1990-04-18	Pfizer Ltd	Therapeutic agents
US5208236A (en) *	1992-09-23	1993-05-04	Schering Corporation	N-(acylaminomethyl)glutaryl amino acids and use
IL139457A0 (en)	1999-11-08	2001-11-25	Pfizer	Compounds for the treatment of female sexual dysfunction
US20020052370A1 (en) *	2000-07-06	2002-05-02	Barber Christopher Gordon	Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase

2002
- 2002-03-18 IL IL15700902A patent/IL157009A0/xx unknown
- 2002-03-18 CZ CZ20032534A patent/CZ20032534A3/cs unknown
- 2002-03-18 JP JP2002577770A patent/JP4018545B2/ja not_active Expired - Fee Related
- 2002-03-18 SK SK1182-2003A patent/SK11822003A3/sk unknown
- 2002-03-18 GE GE5313A patent/GEP20063783B/en unknown
- 2002-03-18 CA CA002437113A patent/CA2437113A1/fr not_active Abandoned
- 2002-03-18 CN CNB028054091A patent/CN1243723C/zh not_active Expired - Fee Related
- 2002-03-18 EA EA200300777A patent/EA006154B1/ru unknown
- 2002-03-18 EP EP02707042A patent/EP1373192A1/fr not_active Withdrawn
- 2002-03-18 WO PCT/IB2002/000807 patent/WO2002079143A1/fr active IP Right Grant
- 2002-03-18 EE EEP200300469A patent/EE200300469A/xx unknown
- 2002-03-18 DO DO2002000364A patent/DOP2002000364A/es unknown
- 2002-03-18 KR KR1020037012690A patent/KR100564466B1/ko not_active IP Right Cessation
- 2002-03-18 BR BR0208455-4A patent/BR0208455A/pt not_active IP Right Cessation
- 2002-03-18 HU HU0303624A patent/HUP0303624A3/hu unknown
- 2002-03-18 OA OA1200300204A patent/OA12553A/en unknown
- 2002-03-18 RS YU75303A patent/RS75303A/sr unknown
- 2002-03-18 NZ NZ527012A patent/NZ527012A/en unknown
- 2002-03-18 MX MXPA03006597A patent/MXPA03006597A/es active IP Right Grant
- 2002-03-18 PL PL02365101A patent/PL365101A1/xx not_active Application Discontinuation
- 2002-03-22 TW TW091105650A patent/TWI254038B/zh not_active IP Right Cessation
- 2002-03-25 UY UY27227A patent/UY27227A1/es not_active Application Discontinuation
- 2002-03-26 MY MYPI20021077A patent/MY134081A/en unknown
- 2002-03-26 PE PE2002000240A patent/PE20021014A1/es not_active Application Discontinuation
- 2002-03-26 AR ARP020101114A patent/AR035795A1/es unknown
- 2002-03-27 TN TNTNSN02032A patent/TNSN02032A1/fr unknown
- 2002-03-27 PA PA20028542401A patent/PA8542401A1/es unknown
- 2002-03-28 AP APAP/P/2002/002467A patent/AP1689A/en active
2003
- 2003-07-17 IS IS6877A patent/IS6877A/is unknown
- 2003-08-13 MA MA27280A patent/MA26996A1/fr unknown
- 2003-08-25 BG BG108130A patent/BG108130A/bg unknown
- 2003-09-17 HR HR20030751A patent/HRP20030751A2/xx not_active Application Discontinuation
- 2003-09-26 NO NO20034299A patent/NO20034299L/no not_active Application Discontinuation
2004
- 2004-05-25 HK HK04103713A patent/HK1060724A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DOP2002000364A (es)	2002-10-15
PE20021014A1 (es)	2002-11-12
NO20034299L (no)	2003-11-27
HK1060724A1 (en)	2004-08-20
HRP20030751A2 (en)	2005-08-31
JP4018545B2 (ja)	2007-12-05
CN1243723C (zh)	2006-03-01
HUP0303624A3 (en)	2005-06-28
CN1492852A (zh)	2004-04-28
NO20034299D0 (no)	2003-09-26
PA8542401A1 (es)	2002-10-28
CZ20032534A3 (cs)	2004-07-14
TWI254038B (en)	2006-05-01
IL157009A0 (en)	2004-02-08
KR20030092032A (ko)	2003-12-03
BG108130A (bg)	2004-07-30
EA006154B1 (ru)	2005-10-27
SK11822003A3 (sk)	2004-09-08
AP1689A (en)	2006-12-07
WO2002079143A1 (fr)	2002-10-10
EA200300777A1 (ru)	2003-12-25
HUP0303624A2 (hu)	2004-03-01
EP1373192A1 (fr)	2004-01-02
BR0208455A (pt)	2004-03-02
JP2004531505A (ja)	2004-10-14
AP2002002467A0 (en)	2002-06-30
UY27227A1 (es)	2002-10-31
RS75303A (en)	2006-12-15
MA26996A1 (fr)	2004-12-20
IS6877A (is)	2003-07-17
CA2437113A1 (fr)	2002-10-10
AR035795A1 (es)	2004-07-14
OA12553A (en)	2006-06-07
MY134081A (en)	2007-11-30
TNSN02032A1 (fr)	2005-12-23
GEP20063783B (en)	2006-04-10
NZ527012A (en)	2005-03-24
KR100564466B1 (ko)	2006-03-29
MXPA03006597A (es)	2004-10-15
EE200300469A (et)	2004-02-16

Publication	Publication Date	Title
IL157009A0 (en)	2004-02-08	N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
EG25482A (en)	2012-01-15	Inhibitors
AU2003260345A1 (en)	2004-02-23	2-phenylpyridin-4-yl derivatives as alk5 inhibitors
HK1071360A1 (en)	2005-07-15	2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AP1850A (en)	2008-05-26	Spiroindolineplperidine derivatives
EG24050A (en)	2008-04-13	Heterocylocarboxamide derivatives
HK1083443A1 (en)	2006-07-07	Thiazolidin-4-ones for inhibiting hyak3 proteins
SI1686119T1 (sl)	2009-12-31	Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
AP2005003343A0 (en)	2005-06-30	Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
DE60329282D1 (de)	2009-10-29	Cyano-pyrrolidine als DPP-IV Inhibitoren
EP1522540A4 (fr)	2011-08-10	Derives d'azaarene
AU2003293356A8 (en)	2004-03-19	Dihydropyridinone derivatives as hne inhibitors
EP1532133A4 (fr)	2006-11-15	Inhibiteurs de nf-:b
PH12004501358B1 (en)	2010-02-08	Small molecule entry inhibitors
EP1506778A4 (fr)	2009-12-16	Inhibiteurs de l'expression du tgf-$g(a)
EG24415A (en)	2009-05-25	Quinoline derivatives
AU2003232362A8 (en)	2003-12-22	4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
GB0305916D0 (en)	2003-04-23	New N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors
AU2003243397A8 (en)	2003-12-19	Homo-camptothecin derivatives
GB0208094D0 (en)	2002-05-22	Inhibitors
GB0217330D0 (en)	2002-09-04	Inhibitors
GB0224102D0 (en)	2002-11-27	Inhibitors
GB0226149D0 (en)	2002-12-18	Inhibitors
GB0207491D0 (en)	2002-05-08	Inhibitors
GB0207488D0 (en)	2002-05-08	Inhibitors

Legal Events

Date	Code	Title	Description
2009-11-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)